Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$0.18 - $0.38 $4,554 - $9,614
25,300 Added 32.99%
102,000 $22,000
Q4 2022

Feb 13, 2023

BUY
$0.16 - $6.5 $3,888 - $157,950
24,300 Added 46.37%
76,700 $25,000
Q3 2022

Nov 14, 2022

BUY
$0.31 - $7.41 $4,402 - $105,222
14,200 Added 37.17%
52,400 $23,000
Q2 2022

Aug 12, 2022

BUY
$0.45 - $1.57 $17,190 - $59,974
38,200 New
38,200 $18,000
Q4 2021

Feb 11, 2022

SELL
$1.19 - $2.42 $368,781 - $749,958
-309,900 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$1.79 - $3.27 $204,675 - $373,904
-114,344 Reduced 26.95%
309,900 $778,000
Q2 2021

Aug 13, 2021

SELL
$1.72 - $3.19 $829,824 - $1.54 Million
-482,456 Reduced 53.21%
424,244 $1.32 Million
Q1 2021

May 13, 2021

BUY
$1.73 - $3.33 $1.54 Million - $2.97 Million
891,300 Added 5787.66%
906,700 $2.13 Million
Q4 2020

Feb 10, 2021

BUY
$1.67 - $2.63 $25,718 - $40,502
15,400 New
15,400 $27,000

Others Institutions Holding VERO

# of Institutions
1
Shares Held
7K
Call Options Held
0
Put Options Held
0

About Venus Concept Inc.


  • Ticker VERO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 65,459,600
  • Market Cap $20.9M
  • Description
  • Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device us...
More about VERO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.